Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

Cancer
Skin Cancer
Malignant Melanoma

Results
Download

Study results

LPS CO39721 Interim Results Cohorts A and B March 2020 English (PDF, 1.9 MB)

LPS CO39721 Interim Results Cohort C March 2020 English (PDF, 1.8 MB)

LPS CO39721 Interim Results Cohort C March2020 Afrikaans (PDF, 0.4 MB)

LPS CO39721 Interim Results Cohort C March 2020 Ukrainian (PDF, 0.4 MB)

LPS CO39721 Interim Results Cohorts A and B March 2020 Spanish (PDF, 0.4 MB)

LPS CO39721 Final Results Cohort C March 2021 English (PDF, 0.4 MB)

LPS CO39721 Final Results Cohorts A and B March 2021 English (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

Study results

LPS CO39721 Interim Results Cohorts A and B March 2020 English (PDF, 1.9 MB)

LPS CO39721 Interim Results Cohort C March 2020 English (PDF, 1.8 MB)

LPS CO39721 Interim Results Cohort C March2020 Afrikaans (PDF, 0.4 MB)

LPS CO39721 Interim Results Cohort C March 2020 Ukrainian (PDF, 0.4 MB)

LPS CO39721 Interim Results Cohorts A and B March 2020 Spanish (PDF, 0.4 MB)

LPS CO39721 Final Results Cohort C March 2021 English (PDF, 0.4 MB)

LPS CO39721 Final Results Cohorts A and B March 2021 English (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma

For the latest version of this information please go to www.forpatients.roche.com